Information Journal Paper
APA:
Copy. (2017). miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells. Journal of drug targeting, 25(2), 125-131. SID. https://sid.ir/paper/733265/en
Vancouver:
Copy. miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells. Journal of drug targeting[Internet]. 2017;25(2):125-131. Available from: https://sid.ir/paper/733265/en
IEEE:
Copy, “miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells,” Journal of drug targeting, vol. 25, no. 2, pp. 125–131, 2017, [Online]. Available: https://sid.ir/paper/733265/en